A novel tumor-promoting mechanism of IL6 and the therapeutic efficacy of tocilizumab: Hypoxia-induced IL6 is a potent autophagy initiator in glioblastoma via the p-STAT3-MIR155-3p-CREBRF pathway. - Xue H; Yuan G; Guo X; Liu Q; Zhang J; Gao X; Xu S; Li T; Shao Q; Yan S; Li G (Autophagy, 2016)